Crouse Steven C. — SEC Form 4 filings
SEC reporting owner CIK 2065241. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-19.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2025-04-21 to 2026-08-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIO-TECHNE Corp (TECH) | President - Diag & Spatial Bi | 5 | — | — | 16 |
| OmniAb, Inc. (OABI) | Director | 4 | — | — | 10 |
Form 4 filings — Crouse Steven C.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-19 | 4 | BIO-TECHNE Corp (TECH) | Grant/award (A): 8,702 (derivative) @ $0 · Grant/award (A): 14,140 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 5,423 @ $0 · Tax withholding (F): 1,947 @ $72.40 · Option exercise (M): 1,379 (derivative) @ $0 · Option exercise (M): 1,868 (derivative) @ $0 · Option exercise (M): 2,176 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | OmniAb, Inc. (OABI) | Option exercise (M): 20,000 · Option exercise (M): 20,000 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 600 · Tax withholding (F): 216 @ $49.77 · Option exercise (M): 600 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 794 · Tax withholding (F): 311 @ $55.02 · Option exercise (M): 794 (derivative) @ $0 | EDGAR |
| 2026-04-21 | 4 | OmniAb, Inc. (OABI) | Option exercise (M): 13,333 · Option exercise (M): 13,333 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | BIO-TECHNE Corp (TECH) | Grant/award (A): 2,387 (derivative) @ $0 · Grant/award (A): 735 (derivative) @ $0 · Grant/award (A): 1,911 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | OmniAb, Inc. (OABI) | Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-04-21 | 4 | OmniAb, Inc. (OABI) | Grant/award (A): 40,000 (derivative) @ $0 · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2065241 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →